Virtu Financial’s LENZ Therapeutics LENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-21,899
Closed -$124K – 2291
2026
Q2
$124K Sell
21,899
-16,621
-43% -$134K ﹤0.01% 1064
2026
Q1
$352K Buy
38,520
+26,173
+212% +$368K 0.01% 738
2025
Q4
$198K Buy
+12,347
New +$360K 0.01% 1028
2024
Q1
– Sell
-4,985
Closed -$91K – 2202
2023
Q4
$91K Buy
+4,985
New +$82.3K 0.01% 1050
2021
Q3
– Sell
-1,101
Closed -$237K – 2041
2021
Q2
$237K Buy
+1,101
New +$192K 0.02% 872

Other funds holding LENZ

Virtu Financial's LENZ Position: Q3 2026 in Review

Virtu Financial sold out of LENZ Therapeutics (LENZ) in Q3 2026, closing a stake of 21,899 shares — an estimated $124K sold.

Virtu Financial first reported a position in LENZ in Q2 2021 and held it in 5 quarters. The position peaked at $352K in Q1 2026. 138 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.

  • Virtu Financial reported no remaining LENZ Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Virtu Financial sold 21,899 LENZ Therapeutics shares in Q3 2026, an estimated $124K.
  • Virtu Financial first reported a position in LENZ Therapeutics in Q2 2021 and held it in 5 quarters.
  • Virtu Financial's LENZ Therapeutics position peaked at $352K in Q1 2026.
  • 138 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.

Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.